CH Robinson Fundamental Analysis: CHRW Revenue, Margins, Debt and Valuation

C.H. Robinson agreed on 5 October 2026 to buy freight broker RXO for an implied USD 5.8bn including debt, and its own shareholders took the bill: the stock closed down 10.85% at USD 140.61, having been off around 10% from the opening bell. RXO holders get USD 17.25 in cash plus 0.0856 C.H. Robinson shares for each share held, an implied USD 30.25 a share, and RXO stock jumped roughly 23% on the news. The consideration is structured so that about 57% is paid in cash and about 43% in new C.H. Robinson stock.

That split is the whole argument. Anyone running a C.H. Robinson fundamental analysis this morning is not really being asked whether truck brokerage consolidation makes industrial sense — it plainly does — but whether USD 300m of promised annual cost synergies is enough to cover a materially larger share count, a materially larger debt load and a target whose own profitability has been thin. On the company's numbers the deal is accretive to adjusted earnings per share within nine months of completion and delivers mid-teens adjusted EPS accretion by 2028. On the market's numbers, as expressed in a one-day move of nearly 11%, the arithmetic is less settled than that.

What C.H. Robinson actually agreed

The definitive agreement, announced on 5 October and filed the same day, values RXO at an implied USD 5.8bn including debt and creates a combined business with an enterprise value of more than USD 25bn. The implied equity value of the consideration is approximately USD 5.3bn. Each RXO share converts into USD 17.25 of cash and 0.0856 of a C.H. Robinson share, for implied total consideration of USD 30.25 — a premium of about 29% to RXO's 2 October close and about 27% to its 90-day volume-weighted average price.

Management expects approximately USD 300m of net run-rate cost synergies within two years of completion, to be delivered by extending what C.H. Robinson calls its Lean AI operating model across the combined network. Completion is guided to the first half of 2027, subject to regulatory clearance, RXO shareholder approval and the usual conditions. S&P Global moved its outlook on C.H. Robinson to negative on the announcement while leaving the company inside investment grade.

The two businesses are not symmetrical, and that matters more than the headline consideration. In its second quarter of 2026, C.H. Robinson reported total revenues up 19.3% to USD 4.9bn, adjusted gross profits up 6.5% to USD 738.0m and net income of USD 186.8m, up 22.5%. Diluted earnings per share of USD 1.56 rose 23.8%; on an adjusted basis EPS of USD 1.61 rose 24.8%. Its adjusted operating margin — a figure C.H. Robinson measures against adjusted gross profits rather than against revenue — came in at 34.7%, an improvement of 360 basis points.

RXO's second quarter looks nothing like that. Revenue of USD 1.8bn was up from USD 1.4bn a year earlier, but adjusted EBITDA was USD 40m, a margin of 2.3%, against USD 38m and 2.7% in the comparable quarter. Brokerage revenue rose 32% to USD 1.3bn and made up 73% of the total. In the first quarter of 2026 RXO's adjusted EBITDA was USD 6m on a 0.4% margin, with brokerage volume down 8% year on year. This is a business that has been winning share through a long freight downturn without yet converting that share into earnings.

Why the market marked the acquirer down

Three things were priced on Monday, and only one was the strategic logic. The first is dilution. Roughly 43% of about USD 5.3bn of equity consideration means approximately USD 2.3bn of new C.H. Robinson stock issued — our own arithmetic from the disclosed split, not a company figure. That is a large issuance against a business earning around USD 187m in a good quarter, and it is being issued to acquire earnings that, on RXO's current run rate, are close to nil.

The second is leverage. The cash portion is approximately USD 3.0bn on the same arithmetic. C.H. Robinson exited the second quarter with long-term debt of USD 1.68bn against cash of USD 154.6m, so net debt of roughly USD 1.5bn. Funding USD 3bn of cash consideration against that starting point is not a marginal change to the balance sheet; it is a different balance sheet. The negative outlook from S&P is the rating agency saying the same thing in its own language.

The third is the synergy number itself. USD 300m of run-rate cost savings is substantial — it is larger than RXO's entire annualised adjusted EBITDA at the second-quarter rate by a wide margin. That is precisely why the market is cautious rather than reassured. When the acquired earnings are small and the promised savings are large, essentially all of the value transfer depends on integration execution. Buyers of the acquirer's stock are being asked to underwrite an operational programme, not an asset.

It is worth being clear about what did not drive the move. This was not a results day, a guidance change or a demand signal. On the most recent reported quarter C.H. Robinson's own trading was improving on every line that matters. The de-rating is a judgement about capital allocation.

The Openbook read

Momentum takes the clearest hit. A single-session fall of nearly 11% in a large-cap industrial is a structural break in a price trend, not noise, and it arrives after a period in which the operating numbers were going the right way. Momentum scores respond to price and to the direction of earnings revisions, and those two have just decoupled: the earnings trend is intact, the price trend is not. Until the market forms a view on the funding, momentum is the factor doing the damage.

Growth improves, mechanically and genuinely. A business with USD 4.9bn of quarterly revenue is adding one running at roughly USD 1.8bn a quarter. Scale in truck brokerage is not cosmetic — density of loads and carriers is the input to both pricing and service — so the combination has a real claim on structurally higher growth than either name alone. The qualification is that bought growth and earned growth are not the same quality, and a score that cannot tell them apart will flatter this deal.

Profitability is diluted on day one and is the factor with the most to prove. C.H. Robinson has been running an adjusted operating margin of 34.7% against adjusted gross profits and has been expanding it by 360 basis points a year. RXO has been running a 2.3% adjusted EBITDA margin on revenue. These are different measures and should not be subtracted from one another, but the direction is not in doubt: blending in a business at RXO's current profitability lowers the group average, and the USD 300m of synergies is the bridge back. If that bridge is built on schedule, profitability ends up higher than the standalone path. If it slips, this is a margin-dilutive deal for several years.

Solvency is where the thesis is actually decided, and it weakens. Tripling net debt in a cyclical, working-capital-hungry brokerage model reduces the room to absorb a bad freight year. C.H. Robinson has historically carried a light balance sheet precisely because its earnings are cycle-exposed; it is giving some of that insurance up. The rating remains investment grade and the outlook is negative, which is a fair summary: no immediate distress, less margin for error.

Reward/Risk is the composite, and it has become more two-sided rather than simply worse. The reward case is that the market has repriced the acquirer by a double-digit percentage on day one for a deal that, if delivered, adds mid-teens EPS accretion by 2028 — the de-rating happens immediately and the accretion arrives later. The risk case is that there are now three ways to lose where there was one: integration slippage, a freight cycle that stays soft through a period of elevated leverage, and the regulatory review. The distribution of outcomes has widened at both ends — the honest description of a transformational deal funded partly in stock. What would move these scores is specific: synergy capture tracking the two-year path in the first reported quarters after completion, and net debt falling rather than drifting.

The read-across

For RXO holders the position has changed in kind. The shares now largely track the deal rather than the freight cycle — a fixed cash component plus a floating 0.0856 of C.H. Robinson stock — which means the acquirer's share price is now part of the value RXO shareholders receive. Monday's move in the acquirer reduced the implied consideration even as the headline USD 30.25 stayed on the page. That mechanic is worth understanding before reading any stated premium as a settled number.

For the wider asset-light logistics group, the signal is consolidation at the top of a fragmented market after a prolonged downturn. The names in the same flow — XPO and GXO in contract logistics, both former corporate siblings of RXO — face two competing thoughts. One is that a larger, more efficient brokerage franchise is a tougher competitor on price. The other is that a deal on these terms sets a reference point for what scale in brokerage is worth to a strategic buyer. Those pull in opposite directions, and which dominates depends largely on whether the peer is more plausibly a buyer or a target.

For the asset-based truckload carriers the read is milder but real. A more concentrated brokerage layer with a declared cost-efficiency agenda is a counterparty with more negotiating weight. That is a slow effect, visible in contract rate season rather than in a single session, and it is the kind of structural shift our screener is more useful for than any one day's price action.

What to watch next

Four markers, in the order they land.

• Financing detail. The exact shape of the roughly USD 3bn cash funding — term loan, bond issuance, or a mix — and its cost. This is the single biggest swing factor on the accretion claim, because interest expense comes straight off the synergy number.
• The next reported quarter. C.H. Robinson's third-quarter 2026 results will be the first set of standalone numbers filed since the announcement, and the first chance for management to put detail behind the USD 300m. Watch whether the adjusted operating margin trend of recent quarters holds while attention is on integration planning.
• The RXO shareholder vote and regulatory clearance. Both are conditions to a completion guided for the first half of 2027. Combining two of the largest North American truckload brokers is not an obvious antitrust problem in a market this fragmented, but nor is it a formality, and the review timetable is the main source of date risk.
• Rating actions. With the outlook already negative, the agencies' commentary once the financing structure is public will be the cleanest external read on whether the balance sheet is being stretched or broken.

The event is unambiguous: one of the largest brokerage combinations the sector has seen, struck at a 29% premium, with the acquirer's shareholders absorbing a near-11% repricing for funding it. What remains open is whether USD 300m of cost savings is a floor or a ceiling. Everything in the five-factor picture above — particularly the gap between an improving profitability trend and a weakening solvency position — turns on that number arriving close to schedule.